Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Jan. 01, 2022
Current Assets    
Cash $ 78,373 $ 13,192
Accounts receivable, less allowance for credit losses; $4,549 and $5,449, at December 31, 2022 and January 1, 2022, respectively 155,397 107,372
Costs in excess of billing on uncompleted contracts 39,251 23,121
Inventory, net 67,677 56,596
Prepaid expenses 9,098 9,843
Other current assets 13,381 4,057
Total current assets 363,177 214,181
Right of-use assets, net 44,305 0
Property and equipment, net 42,083 41,607
Intangible assets, net 404,385 436,040
Goodwill 368,204 369,286
Deferred tax asset, net 46,601 58,915
Other assets 1,863 1,973
Total assets 1,270,618 1,122,002
Current Liabilities    
Accounts payable 52,268 54,961
Billing in excess of costs on uncompleted contracts 21,445 23,207
Current maturities of long-term debt 8,347 8,067
Other accrued liabilities 70,551 54,111
Total current liabilities 152,611 140,346
Debt outstanding 0 6,369
Long-term debt, net 699,850 703,718
Deferred tax liability, net 1,927 749
Other long-term liabilities 40,944 2,533
Total liabilities 895,332 853,715
Commitments and Contingencies (Notes 21)
STOCKHOLDERS’ EQUITY    
Common Stock, 825,000,000 shares authorized, $0.0001 par value, 146,703,894 and 146,561,717 shares issued and outstanding at December 31, 2022 and January 1, 2022, respectively 15 15
Additional paid in capital 281,914 277,799
Accumulated other comprehensive loss (4,796) (949)
Retained earnings (accumulated deficit) 98,153 (8,578)
Total stockholders’ equity 375,286 268,287
Total liabilities and stockholders’ equity $ 1,270,618 $ 1,122,002